← Evidence map

ArticleBiomedicines2025

Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD). | Socratic